» Authors » N Enomoto

N Enomoto

Explore the profile of N Enomoto including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 174
Citations 2262
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Karayama M, Masuda J, Mori K, Yasui H, Hozumi H, Suzuki Y, et al.
Clin Transl Oncol . 2020 Jun; 23(2):418-423. PMID: 32533317
Purpose: Tryptophan metabolites have immunomodulatory functions, suggesting possible roles in cancer immunity. Methods: Plasma tryptophan metabolites were measured using liquid chromatography/mass spectrometry before immune checkpoint inhibitors (ICIs) in patients with...
2.
Karayama M, Inui N, Mori K, Kono M, Hozumi H, Suzuki Y, et al.
Clin Exp Allergy . 2018 Jan; 48(3):278-287. PMID: 29315896
Background: Respiratory impedance comprises the resistance and reactance of the respiratory system and can provide detailed information on respiratory function. However, details of the relationship between impedance and morphological airway...
3.
Satake Y, Nakamura Y, Kono M, Hozumi H, Nagata T, Tsujimura K, et al.
Int J Tuberc Lung Dis . 2017 Apr; 21(5):523-530. PMID: 28399967
Objective: Application of immunotherapy using dendritic cells (DCs) is considered an effective treatment strategy against persistent Mycobacterium tuberculosis infection. With the goal of developing improved therapeutic vaccination strategies for patients...
4.
Matsuura K, Tanaka Y, Watanabe T, Fujiwara K, Orito E, Kurosaki M, et al.
J Viral Hepat . 2014 Apr; 21(7):466-74. PMID: 24750345
Inosine triphosphatase (ITPA) genetic variants are strongly associated with ribavirin (RBV)-induced anaemia during pegylated interferon (PEG-IFN) plus RBV therapy. However, the treatment efficacy of ITPA genetic variants has not been...
5.
Shindo H, Maekawa S, Komase K, Miura M, Kadokura M, Sueki R, et al.
J Viral Hepat . 2013 Mar; 20(4):281-9. PMID: 23490373
Genetic variation in the IL-28B (interleukin-28B; interferon lambda 3) region has been associated with sustained virological response (SVR) rates in patients with chronic hepatitis C treated with peginterferon-α and ribavirin....
6.
Karayama M, Inui N, Suda T, Nakamura Y, Enomoto N, Chida K
Sarcoidosis Vasc Diffuse Lung Dis . 2013 Jan; 29(1):69-73. PMID: 23311128
Background: Pulmonary dendritic cells (DCs) are key regulators of immune responses. An increased accumulation of DCs was reported in the lungs of patients with idiopathic interstitial pneumonia (IIP). Objective: This...
7.
Suda T, Hashizume H, Aoshima Y, Yokomura K, Sato J, Inui N, et al.
Eur Respir J . 2007 Mar; 29(3):612-3. PMID: 17329497
No abstract available.
8.
Itsui Y, Sakamoto N, Kurosaki M, Kanazawa N, Tanabe Y, Koyama T, et al.
J Viral Hepat . 2006 Sep; 13(10):690-700. PMID: 16970601
Type-I interferons (IFNs) and the interferon-stimulated genes (ISGs) play a major role in antivirus responses against hepatitis C virus (HCV) infection. In this study, we studied expression profiles of ISGs...
9.
Kohashi T, Maekawa S, Sakamoto N, Kurosaki M, Watanabe H, Tanabe Y, et al.
J Viral Hepat . 2006 Aug; 13(9):582-90. PMID: 16907844
The number of amino acid substitutions in the interferon sensitivity-determining region (ISDR) in the nonstructural 5A (NS5A) gene of hepatitis C virus (HCV) is closely associated with the interferon (IFN)...
10.
Suda T, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Naito T, et al.
Eur Respir J . 2006 Jul; 28(5):1005-12. PMID: 16837503
The aim of the present study was to clarify the clinical characteristics and prognosis of patients with interstitial lung disease (ILD) associated with amyopathic dermatomyositis (ILD-ADM). The study consisted of...